Abstract
Since OptiVol fluid status monitoring (Medtronic, Inc., Minneapolis, MN) was released to the market in 2004, the manufacturer has been working together with clinicians to better understand the operation and utility of OptiVol in a clinical setting. This has been done through completed and ongoing clinical studies and through evaluation of case studies submitted by clinicians. In the process, much has been learned about some interesting aspects of OptiVol fluid status monitoring and its use with patients with heart failure.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
